This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring
Save the dateMarch 17–19, 2025 | Milan, Italy

Scarlet Therapeutics Ltd


Scarlet Therapeutics is developing a unique platform that makes modified therapeutic red blood cells to potentially treat a wide range of diseases. Initially targeted at the rare metabolic diseases, hyperammonemia and hyperoxaluria, this approach could be used more broadly to target cancer and autoimmune diseases. Modified red blood cells have many unique qualities, including pervasive reach throughout the body, a long active life and the ability to carry therapeutic proteins.